Crude mortality rates and age- and gender-adjusted HRs of death in participants without cancer and without venous thrombosis, with venous thrombosis only, with cancer only, and with cancer-related venous thrombosis (The Tromsø study 1994-2007)
| Exposure . | PY . | Deaths (n) . | MR per 100 PY (95% CI) . | HR (95% CI) . |
|---|---|---|---|---|
| None | 277 713 | 1750 | 0.63 (0.60-0.66) | 1.0 (reference) |
| VT only | 1317 | 67 | 5.1 (4.0-6.4) | 2.6 (2.0-3.3) |
| Cancer only | 5650 | 721 | 12.7 (11.9-13.7) | 7.4 (6.8-8.2) |
| Cancer-related VT | 131 | 72 | 55.0 (43.6-69.3) | 31.2 (24.6-39.6) |
| Exposure . | PY . | Deaths (n) . | MR per 100 PY (95% CI) . | HR (95% CI) . |
|---|---|---|---|---|
| None | 277 713 | 1750 | 0.63 (0.60-0.66) | 1.0 (reference) |
| VT only | 1317 | 67 | 5.1 (4.0-6.4) | 2.6 (2.0-3.3) |
| Cancer only | 5650 | 721 | 12.7 (11.9-13.7) | 7.4 (6.8-8.2) |
| Cancer-related VT | 131 | 72 | 55.0 (43.6-69.3) | 31.2 (24.6-39.6) |
HRs were calculated by means of a time-dependent Cox regression analysis. MR, mortality rate; PY, person-years; VT, venous thrombosis.